Sekisui Medical Co. Ltd., the medical arm of Japanese chemicals group Sekisui Chemical Co., Ltd, has bulked up its diagnostics business with the acquisition of Veredus Laboratories, a Singapore-based multiplex molecular diagnostics specialist.
The deal, of which financial details were not disclosed, is Sekisui's second acquisition since the company – in its Hiyaku 2020 midterm management plan, announced in 2016 – identified "diagnostic...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?